药品契约製造的全球市场规模、份额和成长分析：按服务、按最终用户、按地区 - 行业预测（2024-2031）

2022年全球药品契约製造市场规模预计为190亿美元，预测期内（2024-2031年）复合年增长率为5.9%，从2023年的201.2亿美元增至2031年的3180亿美元，预计将增长至2000万美元。

由于几个关键驱动因素，全球药品契约製造市场正在强劲成长。在这一领域，将药品生产外包给专业的第三方製造商可以使製药公司专注于其核心职能。关键的成长要素包括对具有成本效益的製造的需求不断增加、向灵活製造的转变以及外包非核心业务的趋势不断增长。此外，药物开发的复杂性和对专业製造能力的需求正在推动市场扩张。竞争格局包括许多提供各种契约製造服务的大公司。由于先进技术的采用和药品供应链的预期全球化，预计未来几年市场将持续成长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析和影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究

药品契约製造市场规模：依服务划分，复合年增长率（2024-2031）

• 药品製造服务
• 药物开发服务
• 生技药品製造服务
• 包装和标籤服务
• 灌装和整理服务
• 其他服务

药品契约製造市场规模：依最终用户划分，复合年增长率（2024-2031）

• 大型製药公司
• 中小型製药公司
• 学名药公司
• 其他最终用户

药品契约製造市场规模：按地区，复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Thermo fisher scientific inc.
• Lonza
• Catalent, inc.
• Wuxi apptec
• Sharp Services, LLC
• Samsung biologics
• Boehringer ingelheim international gmbh
• Evonik industries ag
• Fujifilm holdings corporation
• Abbvie inc.
• Siegfried holding ag
• Merck kgaa
• Almac group
• Charles river laboratories
• Asymchem inc.
• Vetter pharma
• Alcami corporation
• Piramal pharma solutions
• Syngene international limited
• Cambrex corporation

结论和建议

Global Pharmaceutical Contract Manufacturing Market size was valued at USD 19 billion in 2022 and is poised to grow from USD 20.12 billion in 2023 to USD 31.82 billion by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

The Global Pharmaceutical Contract Manufacturing market is experiencing robust growth, fueled by several key drivers. This sector involves outsourcing drug production to specialized third-party manufacturers, enabling pharmaceutical companies to concentrate on their core functions. Key growth factors include a rising demand for cost-effective production, a shift towards flexible manufacturing, and an increasing tendency to outsource non-core activities. Furthermore, the complexity of drug development and the necessity for specialized manufacturing capabilities are propelling market expansion. The competitive landscape features numerous major players providing diverse contract manufacturing services. With the anticipated adoption of advanced technologies and the globalization of pharmaceutical supply chains, the market is poised for sustained growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Contract Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Contract Manufacturing Market Segmental Analysis

Global Pharmaceutical Contract Manufacturing Market is segmented by Services, End User and Region. Based on Services, the market is segmented into Pharmaceutical manufacturing services, Drug development services, Biologics manufacturing services, Packaging & labelling services, Fill-finish services, and Other services. Based on End User, the market is segmented into Big pharmaceutical companies, Small & medium-sized pharmaceutical companies, Generic pharmaceutical companies, and Other end users. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Contract Manufacturing Market

A key driver of the Global Pharmaceutical Contract Manufacturing market is the rising demand for cost-effective and efficient manufacturing solutions. Pharmaceutical companies are increasingly turning to contract manufacturing organizations (CMOs) to outsource their production processes, aiming to lower operational expenses and concentrate on their core strengths. This strategic shift not only enables them to tap into specialized expertise and advanced technologies but also facilitates streamlined operations, improved resource management, and faster time-to-market for their products. As a result, this trend significantly enhances their competitiveness in the pharmaceutical landscape, driving growth within the contract manufacturing sector.

Restraints in the Global Pharmaceutical Contract Manufacturing Market

One significant restraint impacting the Global Pharmaceutical Contract Manufacturing market is the stringent regulatory requirements and quality standards that govern the industry. Contract Manufacturing Organizations (CMOs) are obligated to comply with a variety of regulatory frameworks, including Good Manufacturing Practices (GMP), which are critical for ensuring the safety, efficacy, and quality of pharmaceutical products. Adhering to these regulations often demands substantial investments in infrastructure, advanced equipment, and skilled personnel, which can be both time-consuming and costly. Non-compliance poses serious risks, including regulatory penalties, damage to reputation, and potential product recalls, creating considerable challenges for CMOs operating in this market.

Market Trends of the Global Pharmaceutical Contract Manufacturing Market

The global pharmaceutical contract manufacturing market is witnessing a robust trend of increasing outsourcing by pharmaceutical companies, driven by significant factors such as cost efficiency, enhanced production flexibility, and the need for specialized skills. As companies seek to streamline operations and allocate resources more effectively, reliance on contract manufacturing organizations (CMOs) has surged, enabling firms to concentrate on their core areas like research and development. This shift not only facilitates scalability but also accelerates time-to-market for new drugs, fostering innovation within the industry. As a result, CMOs are becoming critical partners in navigating the complexities of pharmaceutical production.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Pharmaceutical Contract Manufacturing Market Size by Services & CAGR (2024-2031)

• Pharmaceutical manufacturing services
• Drug development services
• Biologics manufacturing services
• Packaging & labelling services
• Fill-finish services
• Other services

Global Pharmaceutical Contract Manufacturing Market Size by End User & CAGR (2024-2031)

• Big pharmaceutical companies
• Small & medium-sized pharmaceutical companies
• Generic pharmaceutical companies
• Other end users

Global Pharmaceutical Contract Manufacturing Market Size by Region & CAGR (2024-2031)

• North America (Services, End User)
  • US
  • Canada
• Europe (Services, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Services, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Services, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Services, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo fisher scientific inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi apptec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer ingelheim international gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik industries ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm holdings corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbvie inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siegfried holding ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck kgaa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles river laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asymchem inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcami corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal pharma solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene international limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation